Skip to content

Effect of Trikatwadi Guti in Vatarakta

Randomized Controlled Clinical Trial of Trikatwadi Guti Versus Kaishora Guggulu in Management of Vatarakta with special reference to Gouty Arthritis - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105001
Enrollment
74
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M259- Joint disorder, unspecified

Interventions

None listed

Sponsors

Dr Anuja Nitin Mhetre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with lakshanas of Sandhishotha Sandhisthabdhta Sparshasahtya Tamravarna Patients with Serum Uric Acid greater than 7 mg dl

Exclusion criteria

Exclusion criteria: Pregnancy and Lactating women Patients with major sysytemic illness like SLE Cancer Patients having joint deformities ulcerative changes

Design outcomes

Primary

MeasureTime frame
Trikatwadi Guti is effective in management of VataraktaTimepoint: 7th,14th,21th,28th day

Secondary

MeasureTime frame
Kaishor Guggulu is effective in management of VataraktaTimepoint: 7th,14th,21th,28th day

Countries

India

Contacts

Public ContactDr Sushant Tanaji Kanase

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Center Ashta

sushantkanase@gmail.com8308225960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026